PATENT CLAIM ANALYSIS

Application Number: 16308690
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["546", "277700"]

Abstract:
The present invention concern a 2-oxo-1,2-dihydropyridine-3-carboxamide compound of Formula (I) in the treatment of pathologies which require a dual inhibitor of PDK1/AurA enzymes such as for instance tumours, particularly glioblastoma.

Claim (Index 12):
A 2-oxo-1,2-dihydropyridine-3-carboxamide compound of Formula (I) or a pharmaceutical salt thereof wherein B is CH-D, where D is imidazolyl; and A is selected from the group consisting of (\u2014NH\u2014CO\u2014CH 2 \u2014), (\u2014NH\u2014CO\u2014CH(Ph)-) and (\u2014NH\u2014CO\u2014CH 2 \u2014CH 2 \u2014CH 2 ) R 1  is H or CH 3 , R 2  is H or Br or R 1  and R 2  together represent the group \u2014(N\u2550CH\u2014CH\u2550C)\u2014 with the proviso that when A is (\u2014NH\u2014CO\u2014CH 2 \u2014CH 2 \u2014CH 2 ) then R 1  and R 2  are H and when A is (\u2014NH\u2014CO\u2014CH 2 \u2014) or (\u2014NH\u2014CO\u2014CH(Ph)-), then R 1  and R 2  are not simultaneously H.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 98.0
- Lexical Diversity: 1.09677
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15735468', '13855916', '13699547', '13148903', '13651312']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8307988886863648
- 35 USC 102 Novelty (BERT): 0.6271068198647315
- Combined Prediction Score: 0.8104296818042014
- Mean Citation Score: 396.819224
- Max Citation Score: 671.692
- Similarity Product: 525.6671504263878

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test